Literature DB >> 22653536

Prenatal healthcare providers' Gaucher disease carrier screening practices.

Dana Falcone1, Elisabeth McCarty Wood, Michael Mennuti, Sharon X Xie, Vivianna M Van Deerlin.   

Abstract

PURPOSE: Gaucher disease carrier screening is controversial in the medical community. The goal of this study was to explore current Gaucher disease carrier screening practices of prenatal healthcare providers.
METHODS: Prenatal healthcare providers were invited by email to complete an electronic-based survey.
RESULTS: A total of 1,454 prenatal healthcare providers, including 209 genetic counselors, 450 midwives, and 795 physicians, completed the study. The majority of genetic counselors (n = 208/209, >99%), physicians (n = 415/450, 92%), and midwives (n = 634/795, 80%) currently offer Jewish ancestry disease carrier screening to couples in whom one or both partners are Jewish. Of providers who offer Jewish ancestry disease screening, the majority of genetic counselors (n = 199/208, 96%) and physicians (n = 352/415, 85%) always or sometimes offer Gaucher disease screening whereas the majority of midwives (n = 357/634, 56%) never offer Gaucher disease screening.
CONCLUSION: This study presents the first report of Gaucher disease carrier screening practices of the prenatal healthcare providers in North America. Our results indicate that Gaucher disease carrier screening is being offered at a high rate within the scope of Jewish ancestry-based carrier screening. This may highlight a need to move away from the debate as to whether Gaucher disease carrier screening should be offered and, instead, focus on how best to provide Gaucher disease carrier screening services.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22653536      PMCID: PMC3530379          DOI: 10.1038/gim.2012.63

Source DB:  PubMed          Journal:  Genet Med        ISSN: 1098-3600            Impact factor:   8.822


  22 in total

1.  Practice patterns of obstetrician-gynecologists regarding preconception and prenatal screening for cystic fibrosis.

Authors:  Maria A Morgan; Deborah A Driscoll; Michael T Mennuti; Jay Schulkin
Journal:  Genet Med       Date:  2004 Sep-Oct       Impact factor: 8.822

2.  Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease.

Authors:  E Sidransky; M A Nalls; J O Aasly; J Aharon-Peretz; G Annesi; E R Barbosa; A Bar-Shira; D Berg; J Bras; A Brice; C-M Chen; L N Clark; C Condroyer; E V De Marco; A Dürr; M J Eblan; S Fahn; M J Farrer; H-C Fung; Z Gan-Or; T Gasser; R Gershoni-Baruch; N Giladi; A Griffith; T Gurevich; C Januario; P Kropp; A E Lang; G-J Lee-Chen; S Lesage; K Marder; I F Mata; A Mirelman; J Mitsui; I Mizuta; G Nicoletti; C Oliveira; R Ottman; A Orr-Urtreger; L V Pereira; A Quattrone; E Rogaeva; A Rolfs; H Rosenbaum; R Rozenberg; A Samii; T Samaddar; C Schulte; M Sharma; A Singleton; M Spitz; E-K Tan; N Tayebi; T Toda; A R Troiano; S Tsuji; M Wittstock; T G Wolfsberg; Y-R Wu; C P Zabetian; Y Zhao; S G Ziegler
Journal:  N Engl J Med       Date:  2009-10-22       Impact factor: 91.245

3.  ACOG Committee Opinion No. 442: Preconception and prenatal carrier screening for genetic diseases in individuals of Eastern European Jewish descent.

Authors: 
Journal:  Obstet Gynecol       Date:  2009-10       Impact factor: 7.661

4.  Parkinsonism among Gaucher disease carriers.

Authors:  O Goker-Alpan; R Schiffmann; M E LaMarca; R L Nussbaum; A McInerney-Leo; E Sidransky
Journal:  J Med Genet       Date:  2004-12       Impact factor: 6.318

5.  Medical Geneticists' duty to warn at-risk relatives for genetic disease.

Authors:  Marni J Falk; R Beth Dugan; Mary Ann O'Riordan; Anne L Matthews; Nathaniel H Robin
Journal:  Am J Med Genet A       Date:  2003-07-30       Impact factor: 2.802

6.  Primary care physicians' willingness to offer a new genetic test to tailor smoking treatment, according to test characteristics.

Authors:  Alexandra E Shields; Douglas E Levy; David Blumenthal; Douglas Currivan; Mary McGinn-Shapiro; Kevin B Weiss; Recai Yucel; Caryn Lerman
Journal:  Nicotine Tob Res       Date:  2008-06       Impact factor: 4.244

7.  Genotype-phenotype correlations between GBA mutations and Parkinson disease risk and onset.

Authors:  Z Gan-Or; N Giladi; U Rozovski; C Shifrin; S Rosner; T Gurevich; A Bar-Shira; A Orr-Urtreger
Journal:  Neurology       Date:  2008-04-23       Impact factor: 9.910

8.  Ethics and medical genetics in the United States: a national survey.

Authors:  D C Wertz; J C Fletcher
Journal:  Am J Med Genet       Date:  1988-04

Review 9.  Gaucher disease. Current issues in diagnosis and treatment. NIH Technology Assessment Panel on Gaucher Disease.

Authors: 
Journal:  JAMA       Date:  1996-02-21       Impact factor: 56.272

10.  Carrier screening in individuals of Ashkenazi Jewish descent.

Authors:  Susan J Gross; Beth A Pletcher; Kristin G Monaghan
Journal:  Genet Med       Date:  2008-01       Impact factor: 8.822

View more
  6 in total

1.  The genetics and neuropathology of neurodegenerative disorders: perspectives and implications for research and clinical practice.

Authors:  Vivianna M Van Deerlin
Journal:  Acta Neuropathol       Date:  2012-09       Impact factor: 17.088

2.  Connecting Gaucher and Parkinson Disease: Considerations for Clinical and Research Genetic Counseling Settings.

Authors:  Lola Cook; Jeanine Schulze
Journal:  J Genet Couns       Date:  2017-06-30       Impact factor: 2.537

3.  A cross-sectional survey of genetic counselors providing carrier screening regarding GBA variants and Parkinson disease susceptibility.

Authors:  Tara A Jones; Jeanine Schulze; Sharon Aufox; Jason Rothstein; Aishwarya Arjunan
Journal:  J Assist Reprod Genet       Date:  2022-02-11       Impact factor: 3.412

4.  Patients' Opinions on Genetic Counseling on the Increased Risk of Parkinson Disease among Gaucher Disease Carriers.

Authors:  Maureen Mulhern; Louise Bier; Roy N Alcalay; Manisha Balwani
Journal:  J Genet Couns       Date:  2017-09-30       Impact factor: 2.537

Review 5.  The composition and capacity of the clinical genetics workforce in high-income countries: a scoping review.

Authors:  Nick Dragojlovic; Kennedy Borle; Nicola Kopac; Ursula Ellis; Patricia Birch; Shelin Adam; Jan M Friedman; Amy Nisselle; Alison M Elliott; Larry D Lynd
Journal:  Genet Med       Date:  2020-06-24       Impact factor: 8.822

Review 6.  Diagnosing neuronopathic Gaucher disease: New considerations and challenges in assigning Gaucher phenotypes.

Authors:  Emily C Daykin; Emory Ryan; Ellen Sidransky
Journal:  Mol Genet Metab       Date:  2021-01-09       Impact factor: 4.797

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.